Company Expects to Continue Business Operations in the Ordinary Course During Proceedings; Secures Commitment for Approximately $35 Million in DIP Financing to Support Ongoing Operations No Changes to ...
SAN DIEGO, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (BIOR) (“Biora” or the “Company”), a biotech company developing smart pill-based therapeutic platforms, today announced it has ...
Biora Therapeutics announces a Chapter 11 filing to support a sale process and secure up to $10.25 million in financing. Biora Therapeutics, Inc., a biotech company focused on developing smart ...
SAN FRANCISCO, March 23, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (Nasdaq: ME), a leading human genetics and biotechnology company, today announced that it has ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback